Basel, 4 - 5 December 2019

Schedule

Create your personal agenda –check the favourite icon

Dec 409:00
Conference pass

Genomics for better health

Keynotes
Martin Seychell, Deputy General Director, European Commission
Dec 409:40
Conference pass

Keynote Presentation

Keynotes
Hakan Sakul, Vice President and Head of Diagnostics, Pfizer
Dec 410:00
Conference pass

Accelerating Drug Development Using CtDNA

Keynotes
Dec 411:40
Conference pass

Roundtables

Keynotes
"Tissunomics" - how to integrate clinical and molecular data in tissue diagnostics
Santiago Ramon y Cajal, Chairman of Pathology Department, Vall d'Hebron Barcelona Hospital Campus Vall d'Hebron Resesearch Institute
Best preparations for CTC liquid biopsies
Pamela Pinzani, Associate Professor, University of Florence
Consumer genomics; how to do it right
Matthew Ferber, Co-Director of Clinical Molecular Genetics Laboratory, Mayo Clinic
How to integrate liquid biopsies into routine care
Alexandre Harle, Assistant Professor, Institut De Cancérologie De Lorraine
Pre-analytics for digital pathology
Inti Zlobec, Head Of The Translational Research Unit And Colorectal Cancer Research Group Leader, University of Bern
The right tools for the job: which technology for my question?
Edward Oakeley, Senior Group Head, Next Generation Sequencing, Novartis
Dec 413:30
Conference pass
Dec 413:30
Conference pass

Chair's Remarks

Immuno-Oncology & Companion Diagnostics
Hakan Sakul, Vice President and Head of Diagnostics, Pfizer
Dec 413:35
Conference pass

Predicting Breast Cancer Survival using Digital Pathology

Digital Pathology
Fabien Gaire, Global Head Of Pathology And Tissue Analytics, Roche
Dec 413:35
Conference pass

IMI's Cancer-ID standardizing Liquid Biopsies

Circulating Tumour DNA & Liquid Biopsy
Thomas Schlange, Senior Biomarker Scientist And Efpia Coordinator, Bayer
Ralph Graeser, Senior Translational Medicine Expert, Boehringer Ingelheim Pharma GmbH & Co. KG
Dec 413:35
Conference pass

Requirements for successful application of diagnostics in the context of precision medicine

Immuno-Oncology & Companion Diagnostics
Christian Ruiz, Head Diagnotistic Laboratory Department, University Hospital Basel, Medical Genetics & Pathology
Dec 413:35
Conference pass

Molecular Diagnostic Informational Management Systems

Biobanking & Tissue Management
Lina Yuan, Lead Bioinformatician, Royal Marsden NHS Foundation Trust
Dec 414:15
Conference pass

Computational Pathology – integrating data mining into routine clinical practice

Digital Pathology
Dec 414:15
Conference pass

Single cell applications in liquid biopsy

Circulating Tumour DNA & Liquid Biopsy
Bernhard Polzer, Group Head of Cellular and Molecular Diagnostics, Fraunhofer Institute for Toxicology and Experimental Medicine
Dec 414:15
Conference pass

Genomic Profiling in Immunotherapy response

Immuno-Oncology & Companion Diagnostics
James Creeden, Global Medical Director, Foundation Medicine Inc
Dec 414:15
Conference pass

Tissue microdissection and it’s impact on downstream analysis

Biobanking & Tissue Management
Michael Tangrea, Senior Scientific Director, Innovation and Research, Lifebridge Health, Inc.
Dec 415:05
Conference pass
Dec 415:05
Conference pass

Chair's Remarks

Immuno-Oncology & Companion Diagnostics
Hakan Sakul, Vice President and Head of Diagnostics, Pfizer
Dec 415:10
Conference pass

Label-free digital pathology provides automated tissue classification without inter observer variability

Digital Pathology
Klaus Gerwert, Professor, Ruhr University Bochum
Dec 415:10
Conference pass

Novel digital PCR and mutation enrichment technologies for detecting minimal residual disease and monitoring in liquid biopsies

Circulating Tumour DNA & Liquid Biopsy
Mike Makrigiorgos, Professor For Department Of Radiation Oncology, Dana Farber and Harvard Medical School
Dec 415:10
Conference pass

Translating Genomics in Immuno-oncology

Immuno-Oncology & Companion Diagnostics
Sue Griffin, Director of Biology, Immuno-Oncology and Combinations Research Unit, GSK
Dec 415:50
Conference pass

Tissue Microarrays in the era of digital pathology

Digital Pathology
Inti Zlobec, Head Of The Translational Research Unit And Colorectal Cancer Research Group Leader, University of Bern
Dec 415:50
Conference pass

Clinical applications of liquid biopsies

Circulating Tumour DNA & Liquid Biopsy
Janet Jin, Director, Clinical Biomarkers And CDX, AbbVie
Dec 415:50
Conference pass

Clinical relevance of intrinsic subtyping of breast cancer: from PAM50 to Prosigna ®

Immuno-Oncology & Companion Diagnostics
Maggie Cheang, Team Leader, Genomic Analysis – Clinical Trials, Institute of Cancer Research
Dec 415:50
Conference pass

Infrastructures for precision medicine research: Biobanking at a global scale

Biobanking & Tissue Management
Zisis Kozlakidis, Head, Laboratory Services and Biobanking, International Agency for Research on Cancer (IARC/WHO)
Dec 416:50
Conference pass
Dec 416:50
Conference pass

Chair's Remarks

Immuno-Oncology & Companion Diagnostics
Hakan Sakul, Vice President and Head of Diagnostics, Pfizer
Dec 417:15
Conference pass

Presentation to be confirmed

Digital Pathology
Corinna Wolf, Principal Of Clinical Scientist Biomarker Informatics And Biobanking, Merck Biopharma
Dec 417:15
Conference pass

Clinical Utility of Liquid Biopsies in metastatic NSCLC

Circulating Tumour DNA & Liquid Biopsy
Vali Papadimitrakopoulou, Professor Of Medicine And Chief Thoracic Medical Oncology, National Leader Lung-Map, The University of Texas MD Anderson Cancer Center
Dec 417:15
Conference pass

Presentation to be confirmed

Immuno-Oncology & Companion Diagnostics
Dec 417:55
Conference pass

Presentation to be confirmed

Digital Pathology
Maria Hernandez Fuentes, Head of Patient Tissue Analysis, UCB
Dec 417:55
Conference pass

Presentation to be confirmed

Digital Pathology
Corinna Wolf, Principal Of Clinical Scientist Biomarker Informatics And Biobanking, Merck Biopharma
Dec 417:55
Conference pass

Avoiding the Biomarker graveyard-  Jumping the valley of death between academia and industry

Immuno-Oncology & Companion Diagnostics
Christopher Peters, Clinical Senior Lecturer and Consultant Upper GI and General Surgeon, Imperial College London

Create your personal agenda –check the favourite icon

Dec 509:00
Conference pass

Developing Biomarkers for an NTRK Inhibitor in a tissue agnostic indication

Keynotes
Emmanuelle Di Tomaso, Head of Biomarker Oncology, Bayer US LLC
Dec 509:00
Conference pass

Panel Discussion: Genomic Research and Outcomes - an international perspective

Keynotes
Stephanie Devaney, Deputy Director of All Of Us Research Program, National Institutes of Health
Angela Douglas, Deputy Chief Scientific Officer, NHS England
Said Ismail, Director of Qatar Genome Programme, Qatar Foundation
Dec 513:35
Conference pass

Integrated omics for mapping the human proteome in health and disease

Molecular Diagnostics
Cecilia Lindskog, Director Human Tissue Atlas, Uppsala University
Dec 513:35
Conference pass
Dec 513:35
Conference pass

Advancing biomedical research with single cell profiling

Flow Cytometry & Single Cell Analysis
Simone Picelli, Platform Leader Single-Cell Genomics, Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Guglielmo Roma, Global Head Of Genomic Sciences And Technologies, Novartis
Dec 513:35
Conference pass

Precision Medicine in Melanoma

Precision Medicine
Jan Christoph Brase, Precision Medicine Director, Novartis
Dec 513:55
Conference pass

Precision Medicine in Pfizer’s Early Clinical Portfolio

Precision Medicine
Jean-Claude Marshall, Head of Clinical Biomarker Technologies, Pfizer
Dec 514:15
Conference pass

Development of an integrated platform for biomarker and drug target discovery using proteomics

Molecular Diagnostics
Tony Whetton, Director, Stoller Biomarker Discovery Centre
Dec 514:15
Conference pass

Coordinating molecular testing and patient stratification within a national health care system

Cancer Diagnostics
Donald White, Programme Manager, Precision Medicine, Cancer Research UK
Dec 514:15
Conference pass

Presentation to be confirmed

Flow Cytometry & Single Cell Analysis
Jeroen Van Houdt, Omics Group Leader, Janssen Pharmaceutical
Dec 515:20
Conference pass

The bridge between the Genomic and Proteomic fingerprint in response to treatment

Molecular Diagnostics
Mike Baratta, Scientific Director, Chief Of Staff And Clinical Biomarker Development And Innovation, Takeda Pharmaceutical Company
Dec 515:20
Conference pass

How the Molecular Tumor Board Adds Value to Precision Oncology

Cancer Diagnostics
Anna Berry, Scientific Director Of Personalized Medicine And Medical Director Of Molecular Diagnostics, Swedish Cancer Institute
Dec 515:20
Conference pass

Presentation to be confirmed

Flow Cytometry & Single Cell Analysis
Michael Sinosich, Scientific Director, Prenatal Testing, Sonic Healthcare Ltd
Dec 515:20
Conference pass

Transitioning complex cancer genomics into routine oncology practice

Precision Medicine
Dr Philip Beer, Physician Scientist And Precision Oncology Specialist, Sanger Institute
Dec 516:00
Conference pass

Personalized medicine; more than planning, doing

Molecular Diagnostics
Matthew Ferber, Co-Director of Clinical Molecular Genetics Laboratory, Mayo Clinic
Dec 516:00
Conference pass

Clinical Application of Molecular Tumor Profiling for Best Oncology Care

Cancer Diagnostics
Martin Zoche, Director of Molecular Tumour Profiling, University Hospital Zurich
Dec 516:00
Conference pass

Perspectives from a core facility

Flow Cytometry & Single Cell Analysis
Ulrich Kadolsky, Senior Bioinformatician, GSTT And KCL BRC Genomics Research Platform
Dec 516:00
Conference pass
Dec 517:05
Conference pass

Molecular Pathology in the Netherlands

Molecular Diagnostics
Ed Schuuring, Professor in Molecular Oncological Pathology, University Medical Center Groningen
Dec 517:05
Conference pass

Cancer genomics portfolio for diagnostics, clinical trials and translational research in the Stockholm healthcare region

Cancer Diagnostics
Valtteri Wirta, Head of Unit Clinical Genomics Science for Life Laboratory, Karolinska Institutet
Dec 517:05
Conference pass

The Many Genomes of Prostate Cancer

Precision Medicine
Michael Fraser, Director of Prostate Cancer Research, Ontario Institute for Cancer Research
Dec 517:45
Conference pass

MiRNAs as a diagnostic tool to predict Blood Brain Barrier impairment

Molecular Diagnostics
Frederic Raymond, Team Leader Genomics, Head of Laboratory, Nestle Institute of Health Sciences
Dec 517:45
Conference pass

WHO International Standards for Cancer Genomic Diagnostics

Cancer Diagnostics
Angela Pia Sanzone, Scientist, NIBSC
last published: 13/Jun/19 14:25 GMT

Sign Up for Event Updates

Contact us

To sponsor or exhibit contact:
Harry Ludbrook
+44 (0)207 092 1049

Harry.Ludbrook@terrapinn.com


To speak:
Diana Georgi
+44 (0)20 7092 1075

Diana.georgi@terrapinn.com